380 related articles for article (PubMed ID: 25303478)
21. Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database.
Merola JF; Patil D; Egana A; Steffens A; Webb NS; Gottlieb AB
Dermatol Ther (Heidelb); 2023 Nov; 13(11):2635-2648. PubMed ID: 37726542
[TBL] [Abstract][Full Text] [Related]
22. Health care utilization and costs in type 2 diabetes mellitus and their association with renal impairment.
Burke J; Kovacs B; Borton L; Sander S
Postgrad Med; 2012 Mar; 124(2):77-91. PubMed ID: 22437218
[TBL] [Abstract][Full Text] [Related]
23. Association of Behçet disease with psoriasis and psoriatic arthritis.
Hahn HJ; Kwak SG; Kim DK; Kim JY
Sci Rep; 2021 Jan; 11(1):2531. PubMed ID: 33510251
[TBL] [Abstract][Full Text] [Related]
24. The direct cost of care for psoriasis and psoriatic arthritis in the United States.
Javitz HS; Ward MM; Farber E; Nail L; Vallow SG
J Am Acad Dermatol; 2002 Jun; 46(6):850-60. PubMed ID: 12063481
[TBL] [Abstract][Full Text] [Related]
25. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and economic burden of comorbid anxiety and depression among patients with moderate-to-severe psoriasis.
Cai Q; Teeple A; Wu B; Muser E
J Med Econ; 2019 Dec; 22(12):1290-1297. PubMed ID: 31262226
[No Abstract] [Full Text] [Related]
27. Health Care Utilization and Economic Burdens of Hemochromatosis in the United States: A Population-Based Claims Study.
Elsaid MI; John T; Li Y; Koduru S; Ali SZ; Catalano C; Narayanan N; Rustgi VK
J Manag Care Spec Pharm; 2019 Dec; 25(12):1377-1386. PubMed ID: 31778618
[TBL] [Abstract][Full Text] [Related]
28. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
29. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
[TBL] [Abstract][Full Text] [Related]
30. Early diagnosis of psoriatic arthritis among psoriasis patients: clinical experience sharing.
Su YJ
Clin Rheumatol; 2020 Dec; 39(12):3677-3684. PubMed ID: 32468320
[TBL] [Abstract][Full Text] [Related]
31. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
[TBL] [Abstract][Full Text] [Related]
32. A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients.
Chastek B; White J; Van Voorhis D; Tang D; Stolshek BS
Adv Ther; 2016 Apr; 33(4):626-42. PubMed ID: 26970958
[TBL] [Abstract][Full Text] [Related]
33. Rationale and Design of the Brigham Cohort for psoriasis and psoriatic arthritis registry (COPPAR).
Schneeweiss M; Merola JF; Karlson EW; Solomon DH
BMC Dermatol; 2017 Aug; 17(1):11. PubMed ID: 28814312
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink.
Edson-Heredia E; Zhu B; Lefevre C; Wang M; Barrett A; Bushe CJ; Cox A; Wu JJ; Maeda-Chubachi T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):955-63. PubMed ID: 25352213
[TBL] [Abstract][Full Text] [Related]
35. Drivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan.
Armstrong AW; Zhao Y; Herrera V; Li Y; Bancroft T; Hull M; Altan A
J Drugs Dermatol; 2017 Jul; 16(7):651-658. PubMed ID: 28697216
[TBL] [Abstract][Full Text] [Related]
36. Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis.
Cappell K; Taylor A; Johnson BH; Gelwicks S; Wang S; Gerber M; Leffler DA
Am J Gastroenterol; 2020 Nov; 115(11):1821-1829. PubMed ID: 33156101
[TBL] [Abstract][Full Text] [Related]
37. High-Cost Sarcoidosis Patients in the United States: Patient Characteristics and Patterns of Health Care Resource Utilization.
Rice JB; White A; Lopez A; Nelson WW
J Manag Care Spec Pharm; 2017 Dec; 23(12):1261-1269. PubMed ID: 29172980
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal Signs and Symptoms Related to Inflammatory Bowel Disease in Patients With Moderate-to-Severe Psoriasis.
Feldman SR; Srivastava B; Abell J; Hoops T; Fakharzadeh S; Chakravarty S; Muser E; Dungee D; Quinn S; Leone-Perkins M; Kappelman M
J Drugs Dermatol; 2018 Dec; 17(12):1298-1308. PubMed ID: 30586262
[TBL] [Abstract][Full Text] [Related]
39. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
